Drugs · acquisition-cost intelligence
5 Symptom Digestive Relief
Bismuth· ingredient bismuth subsalicylate· BISMUTH SUBSALICYLATE 262 mg/1; BISMUTH SUBSALICYLATE 525 mg/21
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.08256
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other bismuth subsalicylate products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| CVS Stomach Relief Ultra Strength | $0.01174 | −$0.07080 |
| 5-Symptom Digestive Relief | $0.01247 | −$0.07010 |
| 5-Symptom Digestive Relief | $0.09022 | +$0.00770 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.